APA (7th ed.) Citation

SU, D., AM, S., MP, L., M, M., CH, v. D., JA, F., . . . JW, M. (2015). Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56(10), 1487. https://doi.org/10.2967/jnumed.115.160739

Chicago Style (17th ed.) Citation

SU, Dalm, Sieuwerts AM, Look MP, Melis M, van Deurzen CH, Foekens JA, de Jong M, and Martens JW. "Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 56, no. 10 (2015): 1487. https://doi.org/10.2967/jnumed.115.160739.

MLA (9th ed.) Citation

SU, Dalm, et al. "Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 56, no. 10, 2015, p. 1487, https://doi.org/10.2967/jnumed.115.160739.